Head to Head Survey: Mitsubishi Chemical (OTCMKTS:MTLHY) versus Bit Origin (NASDAQ:BTOG) - Defense World

2022-06-17 08:56:52 By : Mr. Wells Wen

Posted by admin on Jun 16th, 2022

Mitsubishi Chemical (OTCMKTS:MTLHY – Get Rating) and Bit Origin (NASDAQ:BTOG – Get Rating) are both basic materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, profitability, risk, institutional ownership, dividends, valuation and earnings.

This is a breakdown of current ratings and price targets for Mitsubishi Chemical and Bit Origin, as provided by MarketBeat.

Mitsubishi Chemical has a beta of 0.37, indicating that its share price is 63% less volatile than the S&P 500. Comparatively, Bit Origin has a beta of 0.15, indicating that its share price is 85% less volatile than the S&P 500.

0.3% of Bit Origin shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

This table compares Mitsubishi Chemical and Bit Origin’s gross revenue, earnings per share and valuation.

Mitsubishi Chemical has higher revenue and earnings than Bit Origin.

This table compares Mitsubishi Chemical and Bit Origin’s net margins, return on equity and return on assets.

Mitsubishi Chemical beats Bit Origin on 6 of the 8 factors compared between the two stocks.

About Mitsubishi Chemical (Get Rating)

Mitsubishi Chemical Holdings Corporation provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally. The company's performance products include specialty chemicals, functional food materials, inorganic materials, electronic and electrical components and products, molding and processed products, film and sheet products, synthetic paper and fiber, carbon fiber, equipment, instruments and systems, materials and products for industrial use, construction materials, civil engineering materials, aqua-related materials and products, leisure, sports, and daily goods. Its health care products comprise pharmaceuticals, pharmaceutical formulation materials and related products, drug discovery solutions, diagnostic reagents and instruments, health apparatus and instruments for medical use, medical support, nursing care and health support, and clinical examination and service. The company also offers industrial materials, such as basic chemicals, carbon materials, synthetic resins, and industrial gases; and engineering, information systems, analysis and inspection, packaging and logistics, and survey, consulting, and other services. In addition, it manufactures and markets plastic films, house and building materials, infrastructure materials, food and pharmaceutical ingredients, electrolytes for lithium-ion batteries, thermoplastic compounds and functional polyolefin, polyester films, coke, polyethylene, polypropylene, and stainless steel thermoses. Further, the company is involved in the environmental and recycling-related activities, as well as provides warehousing and semiconductor-related services. The company was founded in 2005 and is headquartered in Tokyo, Japan.

About Bit Origin (Get Rating)

Bit Origin Limited engages in the wholesale and retail of feed raw material in China. It distributes feed raw materials consisting of soybean meal and soybean oil. The company sells its products to animal husbandry businesses, feed solution manufacturers, and trading companies. The company was formerly known as China Xiangtai Food Co., Ltd. and changed its name to Bit Origin Limited in April 2022. Bit Origin Limited was incorporated in 2018 and is headquartered in Chongqing, China.

Receive News & Ratings for Mitsubishi Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mitsubishi Chemical and related companies with MarketBeat.com's FREE daily email newsletter.

Harbor Custom Development, Inc. (NASDAQ:HCDI) Director Purchases $15,020.00 in Stock

Weekly Investment Analysts’ Ratings Updates for Titan Pharmaceuticals (TTNP)